Heidbreder Christian's Form 4 filing
Indivior Pharmaceuticals, Inc. (INDV) · filed Jun 12, 2026
- Accession no.
- 0002014639-26-000009
- Filed
- Jun 12, 2026
- Trade date
- Jun 11, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $707.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heidbreder ChristianCIK 0002014639 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | SSaleDisposed | −18,586 | $38.06 | −$707,383.16 | 227,923 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.